Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

EU Transition and Trading Update

Dec 3, 2020Mark EdwardsNews

3 December 2020

ASX ANNOUNCEMENT

EU Transition and Trading Update

Medical Developments International Limited (ASX: MVP) today provides an update in relation to its Penthrox EU transition activities and trading conditions.

Transition arrangements for taking back the distribution rights from Mundipharma in the EU are progressing to plan.  Progress to date includes the establishment of an EU based legal and corporate structure, contracting of pharmacovigilance and regulatory related service providers and securing operational infrastructure in-market, including importation and logistics capability. The Marketing Authorisations previously held by Mundipharma are being transferred concurrently to allow MVP to assume control of sales and distribution activities on 1 March 2021.

Mr. MacGregor said “The opportunity in the EU remains strong and we’re revisiting our execution strategy, assessing and building on the foundation work done by Mundipharma, including determining where we can deploy a direct or hybrid selling model which brings enhanced control and margin.  Europe will be the primary focus of MVP over the coming year.”

Refer to the following link for the full announcement – ASX Announcement – EU Transition and Trading Update

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter